Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.56 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.56 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 5/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.48 |
| ▸ | PAM | P19021 | 2/20 | 0.47 |
| ▸ | MGLL | Q99685 | 1/20 | 0.45 |
| ▸ | PPARG | P37231 | 4/20 | 0.43 |
| ▸ | PPARD | Q03181 | 4/20 | 0.43 |
| ▸ | PPARA | Q07869 | 4/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.43 |
| ▸ | TLR2 | O60603 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28304556 | 1.00 | GPR84 (0.56) | GPR84FFAR1FFAR4TSHRLMNA | |
| SCHEMBL176409 | 1.00 | GPR84 (0.56) | GPR84FFAR1FFAR4TSHRLMNA | |
| SCHEMBL4159638 | 1.00 | GPR84 (0.56) | GPR84FFAR1FFAR4TSHRLMNA | |
| SCHEMBL28287969 | 1.00 | GPR84 (0.56) | GPR84FFAR1FFAR4TSHRLMNA | |
| Ammonia Solution, Strong SCHEMBL27527875 | 0.98 | GPR84 (0.54) | GPR84FFAR1FFAR4TSHRLMNA | |
| Ammonia Solution, Strong SCHEMBL27470632 | 0.98 | GPR84 (0.54) | GPR84FFAR1FFAR4TSHRLMNA | |
| Water SCHEMBL28518811 | 0.98 | GPR84 (0.54) | GPR84FFAR1FFAR4TSHRLMNA | |
| Ammonia Solution, Strong SCHEMBL27593614 | 0.98 | GPR84 (0.54) | GPR84FFAR1FFAR4TSHRLMNA | |
| SCHEMBL26442 | 0.98 | GPR84 (0.52) | GPR84FFAR1FFAR4TSHRLMNA | |
| Ammonia Solution, Strong SCHEMBL7134656 | 0.96 | GPR84 (0.50) | GPR84FFAR1FFAR4TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3193834-B1 | PRE-SPRAY EMULSIONS AND POWDERS CONTAINING NON-POLAR COMPOUNDS | VIRUN INC (US) | 2020-04-01 | — | — | EP | claimed |
| US-10085951-B2 | Curcuminoid formulations and related methods of treatment | DESIGNS FOR HEALTH, INC. (US) | 2018-10-02 | — | — | US | claimed |
| US-10016363-B2 | Pre-spray emulsions and powders containing non-polar compounds | VIRUN, INC. (US) | 2018-07-10 | — | — | US | claimed |
| EP-3193834-A1 | PRE-SPRAY EMULSIONS AND POWDERS CONTAINING NON-POLAR COMPOUNDS | VIRUN, INC. (US) | 2017-07-26 | — | — | EP | claimed |
| US-20160227832-A1 | FORMULATIONS OF WATER-SOLUBLE DERIVATIVES OF VITAMIN E AND COMPOSITIONS CONTAINING SAME | VIRUN, INC. | 2016-08-11 | — | — | US | claimed |
| US-20160166516-A1 | NOVEL CURCUMINOID FORMULATIONS AND RELATED METHODS OF TREATMENT | TCW PT MANAGEMENT COMPANY LLC, AS COLLATERAL AGENT | 2016-06-16 | — | — | US | claimed |
| US-9351517-B2 | Formulations of water-soluble derivatives of vitamin E and compositions containing same | VIRUN, INC. (US) | 2016-05-31 | — | — | US | claimed |
| WO-2016044813-A9 | PRE-SPRAY EMULSIONS AND POWDERS CONTAINING NON-POLAR COMPOUNDS | VIRUN, INC. (US) | 2016-05-26 | — | — | WO | claimed |
| US-20160081927-A1 | PRE-SPRAY EMULSIONS AND POWDERS CONTAINING NON-POLAR COMPOUNDS | VIRUN, INC. | 2016-03-24 | — | — | US | claimed |
| US-20160081975-A1 | SOFT GEL COMPOSITIONS AND PRE-GEL CONCENTRATES | VIRUN, INC. | 2016-03-24 | — | — | US | claimed |
| WO-2016044813-A1 | PRE-SPRAY EMULSIONS AND POWDERS CONTAINING NON-POLAR COMPOUNDS | VIRUN, INC. (US) | 2016-03-24 | — | — | WO | claimed |
| WO-2016044805-A1 | SOFT GEL COMPOSITIONS AND PRE-GEL CONCENTRATES | VIRUN, INC. (US) | 2016-03-24 | — | — | WO | claimed |
| EP-2983525-A1 | FORMULATIONS OF WATER-SOLUBLE DERIVATIVES OF VITAMIN E AND COMPOSITIONS CONTAINING SAME | VIRUN, INC. (US) | 2016-02-17 | — | — | EP | claimed |
| CN-105228470-A | Vitamin E soluble derivative preparation and comprise its composition | VIRUN INC | 2016-01-06 | — | — | CN | claimed |
| WO-2014151109-A1 | FORMULATIONS OF WATER-SOLUBLE DERIVATIVES OF VITAMIN E AND COMPOSITIONS CONTAINING SAME | VIRUN, INC. (US) | 2014-09-25 | — | — | WO | claimed |
| US-20140271593-A1 | FORMULATIONS OF WATER-SOLUBLE DERIVATIVES OF VITAMIN E AND COMPOSITIONS CONTAINING SAME | VIRUN, INC. | 2014-09-18 | — | — | US | claimed |
| US-6140514-A | Process for the preparation of macrocyclic esters or lactones | HUELS AKTIENGESELLSCHAFT (DE) | 2000-10-31 | — | — | US | claimed |
| CN-114524923-B | Biodegradable polyester based on dodecanedioic acid and ethylene glycol, and preparation method and application thereof | 天津工业大学 | 2024-02-27 | — | — | CN | disclosed |
| US-6140514-A | Process for the preparation of macrocyclic esters or lactones | HUELS AKTIENGESELLSCHAFT (DE) | 2000-10-31 | — | — | US | disclosed |
| US-6121466-A | HEATING DICARBOXYLIC ACID (BIS)GLYCOL ESTERS AND GLYCOL; CATALYSIS, DISTILLATION | HUELS AKTIENGESELLSCHAFT (DE) | 2000-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160166516-A1 | NOVEL CURCUMINOID FORMULATIONS AND RELATED METHODS OF TREATMENT | FABP2, SLC46A1, MTHFD2 | GPR84 1167/4885FFAR1 716/4885FFAR4 610/4885 |
| US-10085951-B2 | Curcuminoid formulations and related methods of treatment | MTHFD2, SLC46A1, SLC19A1 | GPR84 1717/4885FFAR1 964/4885FFAR4 818/4885 |
| US-10016363-B2 | Pre-spray emulsions and powders containing non-polar compounds | ELOVL6, ELOVL3, NDUFA6 | GPR84 3398/4885FFAR1 562/4885FFAR4 754/4885 |
| US-20140271593-A1 | FORMULATIONS OF WATER-SOLUBLE DERIVATIVES OF VITAMIN E AND COMPOSITIONS CONTAINING SAME | TTPA, PTGES, HPGDS | GPR84 1227/4885FFAR1 1539/4885FFAR4 1752/4885 |
| US-20160081975-A1 | SOFT GEL COMPOSITIONS AND PRE-GEL CONCENTRATES | ELOVL6, ELOVL3, GSTO1 | GPR84 3855/4885FFAR1 1420/4885FFAR4 1633/4885 |
| US-20160081927-A1 | PRE-SPRAY EMULSIONS AND POWDERS CONTAINING NON-POLAR COMPOUNDS | ELOVL6, ELOVL3, NDUFA6 | GPR84 3398/4885FFAR1 562/4885FFAR4 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.